AMALY — SHARIAH COMPLIANCE REPORT
==================================
Symbol: LNAI
Report Date: 2026-04-06
Full Report: https://amaly.io/stock/LNAI

EXECUTIVE SUMMARY
------------------
Compliance Status: NON_COMPLIANT
Quality Rating: B
Description: Lunai Bioworks Inc. (LNAI), a biotechnology firm in the Healthcare sector, specializes in AI-powered therapeutics and biodefense technologies. This analysis evaluates its Shariah compliance through financial ratios, business activities, index inclusion, ESG factors, and multi-perspective views. The company fails key financial thresholds, particularly debt ratios, and is excluded from major Shariah indices due to leverage and biodefense involvement. While core therapeutic activities are permissible, purification may be required for minor non-compliant elements. Overall, LNAI is classified as non-compliant with a B quality rating, recommending monitoring for potential improvements in debt management.

Primary Compliance Concerns:
- Debt Ratio: 37.24% (exceeds AAOIFI 30%, MSCI 33.33%, S&P 33% thresholds)
- Biodefense activities raising questions on permissibility
- Exclusion from all major Shariah indices

Purification Requirement: 0.00%
Index Inclusion: Excluded from S&P Dow Jones Shariah, MSCI Islamic, FTSE Shariah, and DJIM indices

KEY FINANCIAL METRICS
----------------------
Debt Ratio: 37.2%
Liquidity Ratio: 8.7%
Interest Income Ratio: 0.0%
Purification Required: 0.00%

INDEX INCLUSION STATUS
-----------------------
S&P Shariah: EXCLUDED
MSCI Islamic: EXCLUDED
DJIM: EXCLUDED
FTSE Shariah: EXCLUDED
Total: 0 of 4
Last Verified: 2026-02-28

REPORTING PERIOD
-----------------
Latest Annual Report: FY 2025
Latest Quarterly Data: Q1 2026
Trend Period: FY 2021 to FY 2025
Data Retrieved: 2026-04-02T12:00:00Z

---
Full interactive report: https://amaly.io/stock/LNAI
Provided by Amaly (https://amaly.io) — Shariah Compliant Stock Screener
Disclaimer: This data is for informational purposes only and does not constitute financial or religious advice.